Nebivolol ANOCA Treatment Randomized Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT06755801

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06755801
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06755801. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-01 (anticipated); primary completion 2026-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nebivolol ANOCA Treatment Randomized Trial
Acronym
MOTORS
Condition
ANOCA - Angina With Non-obstructive Coronary Arteries
Condition
Coronary Microvascular Dysfunction (CMD)
Intervention (Drug)
Nevibolol
Intervention (Drug)
Placebo
Lead sponsor
Spanish Society of Cardiology (class: other)

Record details

Record id
cardio:ct-nct06755801
Content hash
5cbb163e0ac4994e0429f500b50f708b33667b5295c7e48fa1d4f71470f3c6d1